Clinical Trial Update: Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing tiotropium inhalation capsules to Combivent inhalation aerosol in COPD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Combivent Inhalation Aerosol (ipratropium bromide/albuterol)
• tiotropium inhalation capsules (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED